Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia

Clinical Infectious Diseases

October 3, 2024

10.1093/cid/ciae500

Cited by 44

Related Papers

No related papers found

Powered by citation graph analysis